Literature DB >> 9148745

Retinol and retinaldehyde specifically increase alpha1-proteinase inhibitor in the human cornea.

G Bosković1, S S Twining.   

Abstract

alpha1-Proteinase inhibitor is a serpin and can inhibit most serine proteinases. The cornea is one of several extrahepatic tissues that synthesizes this inhibitor. In the presence of retinol, corneal alpha1-proteinase inhibitor levels were increased 3.8-fold. The maximal response was achieved 2 h after the addition of retinol (1 microM final concentration) to the culture medium. A similar increase in alpha1-proteinase inhibitor was observed with retinaldehyde (1 nM final concentration). Concentrations of alpha1-proteinase inhibitor in other tested cells (Hep G2, CaCo 2, MCF-7, monocytes and macrophages) remained unchanged in the presence of retinol. Retinoic acid did not affect alpha1-proteinase inhibitor levels in the cornea or the other cells tested. The acute-phase cytokine, interleukin-6, increased alpha1-proteinase inhibitor levels in all tested tissues/cells except the cornea. These results demonstrate that alpha1-proteinase inhibitor levels are controlled differently in the cornea compared with other tissues/cells. alpha1-Proteinase inhibitor is the first protein identified whose levels are regulated by a mechanism supported by retinol and retinaldehyde but not retinoic acid.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9148745      PMCID: PMC1218251          DOI: 10.1042/bj3220751

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.

Authors:  R C Hubbard; F Ogushi; G A Fells; A M Cantin; S Jallat; M Courtney; R G Crystal
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

2.  Transforming growth factor beta 1 regulates production of acute-phase proteins.

Authors:  A Mackiewicz; M K Ganapathi; D Schultz; A Brabenec; J Weinstein; M F Kelley; I Kushner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Interferon beta 2/interleukin 6 modulates synthesis of alpha 1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells.

Authors:  D H Perlmutter; L T May; P B Sehgal
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

4.  Structure of the gene and its retinoic acid-regulatory region for murine J6 serpin. An F9 teratocarcinoma cell retinoic acid-inducible protein.

Authors:  S Y Wang
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

5.  Effect of pseudomonas elastase on human mononuclear phagocyte alpha 1-antitrypsin expression.

Authors:  C Barbey-Morel; D H Perlmutter
Journal:  Pediatr Res       Date:  1991-02       Impact factor: 3.756

6.  In vitro interactions of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, with human serum lipoproteins and albumin.

Authors:  V Carillet; P Morlière; J C Mazière; G Hüppe; R Santus; L Dubertret
Journal:  Biochim Biophys Acta       Date:  1990-11-12

7.  Regulation of synthesis of some proteinase inhibitors in human hepatoma cells HepG2 by cytokines, hepatocyte growth factor and retinoic acid.

Authors:  A Koj; E Korzus; H Baumann; T Nakamura; J Travis
Journal:  Biol Chem Hoppe Seyler       Date:  1993-03

8.  Anhydroretinol: a naturally occurring inhibitor of lymphocyte physiology.

Authors:  J Buck; F Grün; F Derguini; Y Chen; S Kimura; N Noy; U Hämmerling
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

Review 9.  Mammalian alpha 1-antitrypsins: comparative biochemistry and genetics of the major plasma serpin.

Authors:  S D Patterson
Journal:  Comp Biochem Physiol B       Date:  1991

10.  Lipopolysaccharide modulates the expression of alpha 1 proteinase inhibitor and other serine proteinase inhibitors in human monocytes and macrophages.

Authors:  C Barbey-Morel; J A Pierce; E J Campbell; D H Perlmutter
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  5 in total

1.  Regulation of alpha1-proteinase inhibitor release by proinflammatory cytokines in human intestinal epithelial cells.

Authors:  D Faust; K Raschke; S Hormann; V Milovic; J Stein
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  Therapy with plasma purified alpha1-antitrypsin (Prolastin®) induces time-dependent changes in plasma levels of MMP-9 and MPO.

Authors:  Janine Koepke; Marc Dresel; Severin Schmid; Timm Greulich; Björn Beutel; Bernd Schmeck; Claus Franz Vogelmeier; Sabina Janciauskiene; Andreas Rembert Koczulla
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

Review 3.  Human plasma protein N-glycosylation.

Authors:  Florent Clerc; Karli R Reiding; Bas C Jansen; Guinevere S M Kammeijer; Albert Bondt; Manfred Wuhrer
Journal:  Glycoconj J       Date:  2015-11-10       Impact factor: 2.916

4.  Self-renewing Monolayer of Primary Colonic or Rectal Epithelial Cells.

Authors:  Yuli Wang; Matthew DiSalvo; Dulan B Gunasekara; Johanna Dutton; Angela Proctor; Michael S Lebhar; Ian A Williamson; Jennifer Speer; Riley L Howard; Nicole M Smiddy; Scott J Bultman; Christopher E Sims; Scott T Magness; Nancy L Allbritton
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-03-06

5.  Types of acute phase reactants and their importance in vaccination.

Authors:  Rafaat H Khalil; Nabil Al-Humadi
Journal:  Biomed Rep       Date:  2020-02-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.